MD PhD M.C.C.M. Hulshof publications

foto

Publications MD PhD M.C.C.M. Hulshof

Position
Medical Specialist
Main activities
Patient care, Research
Specialisation
esophageal cancer, bladder cancer, hyperthermia, prostate cancer
Focus of research
bladder cancer, oesophageal cancer, hyperthermia

2020

  • Hagens E. R. C., Feenstra M. L., Eshuis W. J., Hulshof M. C. C. M., van Laarhoven H. W. M., van Berge Henegouwen M. I., Gisbertz S. S. Conditional survival after neodjuvant chemotherapy and surgery for oesophageal cancer British journal of surgery 2020 [PubMed]
  • van den Ende Tom, Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Gastro-oesophageal junction: to FLOT or to CROSS? Acta oncologica (Stockholm, Sweden) 2020;59 (2):233-236 [PubMed]
  • Slagter Astrid E., Tudela Benjamin, van Amelsfoort Romy M., Sikorska Karolina, van Sandick Johanna W., van de Velde Cornelis J. H., van Grieken Nicole C. T., Lind Pehr, Nordsmark Marianne, Putter Hein, Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Grootscholten Cecile, Braak Jeffrey P. B. M., Meershoek-Klein Kranenbarg Elma, Jansen Edwin P. M., Cats Annemieke, Verheij Marcel Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial European journal of cancer (Oxford, England 2020;130:146-154 [PubMed]
  • Stroes Charlotte I., Schokker Sandor, Creemers Aafke, Molenaar Remco J., Hulshof Maarten C. C. M., van der Woude Stephanie O., Bennink Roel J., Mathôt Ron A. A., Krishnadath Kausilia K., Punt Cornelis J. A., Verhoeven Rob H. A., van Oijen Martijn G. H., Creemers Geert-Jan, Nieuwenhuijzen Grard A. P., van der Sangen Maurice J. C., Beerepoot Laurens V., Heisterkamp Joos, Los Maartje, Slingerland Marije, Cats Annemieke, Hospers Geke A. P., Bijlsma Maarten F., van Berge Henegouwen Mark I., Meijer Sybren L., van Laarhoven Hanneke W. M. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study Journal of clinical oncology 2020;38 (5):462-471 [PubMed]
  • Groot Harmke J., van Leeuwen Flora E., Lubberts Sjoukje, Horenblas Simon, de Wit Ronald, Witjes J. Alfred, Groenewegen Gerard, Poortmans Philip M., Hulshof Maarten C. C. M., Meijer Otto W. M., de Jong Igle J., van den Berg Hetty A., Smilde Tineke J., Vanneste Ben G. L., Aarts Maureen J. B., Jóźwiak Katarzyna, van den Belt-Dusebout Alexandra W., Gietema Jourik A., Schaapveld Michael Platinum exposure and cause-specific mortality among patients with testicular cancer Cancer 2020;126 (3):628-639 [PubMed]
  • Wortel Kim, Hovius Marina C., van Andel George, de Reijke Theo M., Hulshof Maarten C. C. M. The Feasibility and Utility of Cystoscopy-Guided Hydrogel Marker Placement in Patients With Muscle-Invasive Bladder Cancer Practical radiation oncology 2020 [PubMed]

2019

  • Machiels M. lanie, Voncken Francine E. M., Jin Peng, van Dieren Jolanda M., Bartels-Rutten Annemarieke, Alderliesten Tanja, Aleman Berthe M. P., van Hooft Jeanin E., Hulshof Maarten C. C. M. A Novel Liquid Fiducial Marker in Esophageal Cancer Image Guided Radiation Therapy: Technical Feasibility and Visibility on Imaging Practical radiation oncology 2019;9 (6):506-515 [PubMed]
  • Steins Anne, Ebbing Eva A., Creemers Aafke, van der Zalm Amber P., Jibodh Rajni A., Waasdorp Cynthia, Meijer Sybren L., van Delden Otto M., Krishnadath Kausilia K., Hulshof Maarten C. C. M., Bennink Roelof J., Punt Cornelis J. A., Medema Jan Paul, Bijlsma Maarten F., van Laarhoven Hanneke W. M. Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma International journal of cancer. Journal international du cancer 2019;145 (10):2792-2803 [PubMed]
  • van den Ende Tom, Abe Nijenhuis Frank A., van den Boorn H. ctor G., ter Veer Emil, Hulshof Maarten C. C. M., Gisbertz Suzanne S., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis Frontiers in oncology 2019;9 [PubMed]
  • Hagens Eliza R. C., van Berge Henegouwen Mark I., van Sandick Johanna W., Cuesta Miguel A., van der Peet Donald L., Heisterkamp Joos, Nieuwenhuijzen Grard A. P., Rosman Camiel, Scheepers Joris J. G., Sosef Meindert N., van Hillegersberg Richard, Lagarde Sjoerd M., Nilsson Magnus, Räsänen Jari, Nafteux Philippe, Pattyn Piet, Hölscher Arnulf H., Schröder Wolfgang, Schneider Paul M., Mariette Christophe, Castoro Carlo, Bonavina Luigi, Rosati Riccardo, de Manzoni Giovanni, Mattioli Sandro, Garcia Josep Roig, Pera Manuel, Griffin Michael, Wilkerson Paul, Chaudry M. Asif, Sgromo Bruno, Tucker Olga, Cheong Edward, Moorthy Krishna, Walsh Thomas N., Reynolds John, Tachimori Yuji, Inoue Haruhiro, Matsubara Hisahiro, Kosugi Shin-Ichi, Chen Haiquan, Law Simon Y. K., Pramesh C. S., Puntambekar Shailesh P., Murthy Sudish, Linden Philip, Hofstetter Wayne L., Kuppusamy Madhan K., Shen K. Robert, Darling Gail E., Sabino Flávio D., Grimminger Peter P., Meijer Sybren L., Bergman Jacques J. G. H. M., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Mearadji Banafsche, Bennink Roel J., Annema Jouke T., Dijkgraaf Marcel G. W., Gisbertz Suzanne S. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: Study protocol of a multinational observational study BMC cancer 2019;19 (1) [PubMed]
  • Jin Peng, Machiels Mélanie, Crama Koen F., Visser Jorrit, van Wieringen Niek, Bel Arjan, Hulshof Maarten C.C.M., Alderliesten Tanja Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy International journal of radiation oncology, biology, physics 2019;103 (2):491-502 [PubMed]
  • Boevé Liselotte M. S., Hulshof Maarten C. C. M., Vis André N., Zwinderman Aeilko H., Twisk Jos W. R., Witjes Wim P. J., Delaere Karl P. J., Moorselaar R. Jeroen A. van, Verhagen Paul C. M. S., van Andel George Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial European urology 2019;75 (3):410-418 [PubMed]
  • Anderegg Martinus C. J., Ruurda Jelle P., Gisbertz Suzanne S., Blom Rachel L. G. M., Sosef Meindert N., Wijnhoven Bas P. L., Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I. Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma European journal of surgical oncology 2019 [PubMed]
  • Jin Peng Geometrical variability of esophageal tumors and its implications for accurate radiation therapy 2019. 217p. ISBN 9789402813326. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Rasch C. R. N.; Co-supervisors: Alderliesten T. , Hulshof M. C. C. M.)
  • Jansen Hanneke, van Oort Inge M., van Andel George, Wijsman Bart P., Pos Floris J., Hulshof Maarten C. C. M., Hulsbergen-van de Kaa Christina A., van Leenders Geert J. L. H., Fütterer Jurgen.J., Somford Diederink M., Busstra Martijn B., van Moorselaar Reindert J. A., Kiemeney Lambertus A., Aben Katja K. H. Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors Prostate cancer and prostatic diseases 2019;22 (2):337-343 [PubMed]
  • Boevé Liselotte M. S., Hulshof Maarten C. C. M., Vis André N., de Vries Peter, van Moorselaar R. Jeroen A., Witjes Wim P. J., Verhagen Paul C. M. S., van Andel George Lokale behandeling bij het primair gemetastaseerd prostaatcarcinoom Tijdschrift voor urologie 2019;9 (6-7):103-107
  • Machiels Melanie, van Montfoort Maurits L., Thuijs Nikki B., van Berge Henegouwen Mark I., Alderliesten Tanja, Meijer Sybren L., van Hooft Jeanin E., Hulshof Maarten C. C. M. Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer Radiation oncology (London, England) 2019;14 (1):219 [PubMed]
  • van den Ende Tom, Veer Emilter, Mali Rosa M. A., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. Prognostic and predictive factors for the curative treatment of esophageal and gastric cancer in randomized controlled trials: A systematic review and meta-analysis Cancers 2019;11 (4) [PubMed]
  • Burdett Sarah, Boevé Liselotte M., Ingleby Fiona C., Fisher David J., Rydzewska Larysa H., Vale Claire L., van Andel George, Clarke Noel W., Hulshof Maarten C., James Nicholas D., Parker Christopher C., Parmar Mahesh K., Sweeney Christopher J., Sydes Matthew R., Tombal Bertrand, Verhagen Paul C., Tierney Jayne F. Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis European urology 2019;76 (1):115-124 [PubMed]
  • Machiels M. lanie, Jin Peng, van Hooft Jeanin E., Gurney-Champion Oliver J., Jelvehgaran Pouya, Geijsen Elizabeth D., Jeene Paul M., Willemijn Kolff M., Oppedijk Vera, Rasch Coen. R. N., van Herk Marcel B., Alderliesten Tanja, Hulshof Maarten C. C. M. Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers Acta oncologica (Stockholm, Sweden) 2019:1-8 [PubMed]
  • Jeene Paul M., Geijsen Elisabeth D., Muijs Christina T., Rozema Tom, Aleman Berthe M. P., Muller Karin, Baas Jara M., Nuyttens Joost J., Wouterse Sanne, Braam P. tra M., Oppedijk Vera, Ceha Heleen M., Cnossen Jeltsje, Spruit Patty, Bongers Eva M., Berbée Maaike, Mook Stella, Hulshof Maarten C. C. M. Small cell carcinoma of the esophagus: A nationwide analysis of treatment and outcome at patient level in locoregional disease American journal of clinical oncology 2019;42 (6):534-538 [PubMed]
  • Ebbing Eva A., van der Zalm Amber P., Steins Anne, Creemers Aafke, Hermsen Simone, Rentenaar Rosa, Klein Michelle, Waasdorp Cynthia, Hooijer Gerrit K. J., Meijer Sybren L., Krishnadath Kausilia K., Punt Cornelis J. A., van Berge Henegouwen Mark I., Gisbertz Suzanne S., van Delden Otto M., Hulshof Maarten C. C. M., Medema Jan Paul, van Laarhoven Hanneke W. M., Bijlsma Maarten F. Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma Proceedings of the National Academy of Sciences of the United States of America 2019;116 (6):2237-2242 [PubMed]
  • van den Ende Tom, ter Veer Emil, Machiels M. lanie, Mali Rosa M. A., Abe Nijenhuis Frank A., de Waal Laura, Laarman Marety, Gisbertz Suzanne S., Hulshof Maarten C. C. M., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. The efficacy and safety of (Neo)adjuvant therapy for gastric cancer: A network meta-analysis Cancers 2019;11 (1) [PubMed]
  • Rijksen Barbara Lily Thérèse, Pos Floris J., Hulshof Maarten C. C. M., Vernooij Robin W. M., Jansen Hanneke, van Andel George, Wijsman Bart P., Somford Diederink M., Busstra Martijn B., van Moorselaar Reindert J. A., Kaa Christina A. Hulsbergen-van de, van Leenders Geert J. L. H., Hamberg Paul, van den Berkmortel Franchette, Fütterer Jurgen J., Kiemeney Lambertus A., van Oort Inge M., Aben Katja K. H. Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study European urology focus 2019 [PubMed]

2018

  • Creemers Aafke, Ebbing Eva A., Pelgrim Thomas C., Lagarde Sjoerd M., van Etten-Jamaludin Faridi S., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., Krishnadath Kausilia K., Meijer Sybren L., Bijlsma Maarten F., van Oijen Martijn G. H., van Laarhoven Hanneke W. M. A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas Scientific reports 2018;8 (1) [PubMed]
  • van den Ende Tom, Smyth Elizabeth, Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M. Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer Best practice & research. Clinical gastroenterology 2018;36-37:45-52 [PubMed]
  • Cats Annemieke, Jansen Edwin P. M., van Grieken Nicole C. T., Sikorska Karolina, Lind Pehr, Nordsmark Marianne, Meershoek-Klein Kranenbarg Elma, Boot Henk, Trip Anouk K., Swellengrebel H. A. Maurits, van Laarhoven Hanneke W. M., Putter Hein, van Sandick Johanna W., van Berge Henegouwen Mark I., Hartgrink Henk H., van Tinteren Harm, van de Velde Cornelis J. H., Verheij Marcel, van Coevorden Frits, Vanhoutvin Steven, Hulshof Maarten C. CM, Loosveld Olaf J. L., ten Tije A. (Bert) Jan, Erdkamp Frans L. G., Warmerdam Fabienne A. RM, van der Peet Donald L., Verheul Henk M. W., Boerma Djamila, Los Maartje, Slot Annerie, Houtsma Danny, Portielje Johanna E. A., Blaisse Reinoud J. B., Spillenaar Bilgen Ernst Jan, Polée Marco B., Geenen Maud M., Braak Jeffrey P. BM, Neelis Karen J., Slingerland Marije, Jansen Rob L. H., Buijsen Jeroen, Beeker Aart, Eijsbouts Quirijn A. J., van Riel Johanna M. GH, Rozema Tom, van Spronsen Dick Johan, Meerum Terwogt Jetske M., Tanis Bea C., van der Torren-Conze Adelheid M. E., van Hilligersberg Richard Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial lancet oncology 2018;19 (5):616-628
  • Schooneveldt Gerben, Kok H. Petra, Bakker Akke, Geijsen Elisabeth D., Rasch Coen R. N., de la Rosette Jean J. M. C. H., Hulshof Maarten C. C. M., Reijke Theo M. de, Crezee Hans Clinical validation of a novel thermophysical bladder model designed to improve the accuracy of hyperthermia treatment planning in the pelvic region International journal of hyperthermia 2018;35 (1):383-397 [PubMed]
  • Machiels M. lanie, Jin Peng, van Gurp Christianne H., van Hooft Jeanin E., Alderliesten Tanja, Hulshof Maarten C. C. M. Comparison of carina-based versus bony anatomy-based registration for setup verification in esophageal cancer radiotherapy Radiation oncology (London, England) 2018;13 (1) [PubMed]
  • Slagter Astrid E, Jansen Edwin P M, van Laarhoven Hanneke W M, van Sandick Johanna W, van Grieken Nicole C T, Sikorska Karolina, Cats Annemieke, Muller-Timmermans Pietje, Hulshof Maarten C C M, Boot Henk, Los Maartje, Beerepoot Laurens V, Peters Frank P J, Hospers Geke A P, van Etten Boudewijn, Hartgrink Henk H, van Berge Henegouwen Mark I, Nieuwenhuijzen Grard A P, van Hillegersberg Richard, van der Peet Donald L, Grabsch Heike I, Verheij Marcel CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer BMC cancer 2018;18 (1):877 [PubMed]
  • Jin Peng, Crama Koen F., Visser Jorrit, van Wieringen Niek, Bel Arjan, Hulshof Maarten C. C. M., Alderliesten Tanja Density override in treatment planning to mitigate the dosimetric effect induced by gastrointestinal gas in esophageal cancer radiation therapy Acta oncologica (Stockholm, Sweden) 2018;57 (12):1646-1654 [PubMed]
  • Noordman Bo Jan, Spaander Manon C. W., Valkema Roelf, Wijnhoven Bas P. L., van Berge Henegouwen Mark I., Shapiro Joël, Biermann Katharina, van der Gaast Ate, van Hillegersberg Richard, Hulshof Maarten C. C. M., Krishnadath Kausilia K., Lagarde Sjoerd M., Nieuwenhuijzen Grard A. P., Oostenbrug Liekele E., Siersema Peter D., Schoon Erik J., Sosef Meindert N., Steyerberg Ewout W., van Lanschot J. Jan B., Doukas Michael, Krak Nanda C., Poley Jan-Werner, van Rij Caroline M., Bergman Jaques J. GH. M., Gisbertz Suzanne S., van Laarhoven Hanneke W. M., Meijer Sybren L., Goense Lucas, Haj Mohammad Nadia, Hobbelink Monique G. G., Offerhaus G. Johan A., Vleggaar Frank, Curvers Wouter L., Creemers Geert-Jan, Roef Mark J., van der Sangen Maurice J. C., Buijsen Jeroen, Riedl Robert G., Schreurs Wendy M. J., Warmerdam Fabienne A. RM, Janssen M. J. R., van der Post Chella, Radema Sandra A., Rosman Camiel, Rütten Heidi Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study lancet oncology 2018;19 (7):965-974
  • Noordman Bo Jan, Verdam Mathilde G. E., Lagarde Sjoerd M., Hulshof Maarten C. C. M., van Hagen Pieter, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R., ten Kate Fiebo J. W., Creemers Geert-Jan M., Punt Cornelis J. A., Plukker John Th M., Verheul Henk M. W., Spillenaar Bilgen Ernst J., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., Steyerberg Ewout W., van der Gaast Ate, Sprangers Mirjam A. G., van Lanschot J. Jan B. Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial Journal of clinical oncology 2018;36 (3):268-+ [PubMed]
  • Jelvehgaran Pouya, Alderliesten Tanja, Georgiou Giota, Meijer Sybren L., Bloemen Paul R., Kodach Liudmila L., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M., Rasch Coen R. N., van Leeuwen Ton G., de Boer Johannes F., de Bruin Martijn, van Herk Marcel Feasibility of using optical coherence tomography to detect radiation-induced fibrosis and residual cancer extent after neoadjuvant chemo-radiation therapy: An ex vivo study Biomedical optics express 2018;9 (9):4196-4216 [PubMed]
  • van Putten Margreet, Koëter Marijn, van Laarhoven Hanneke W. M., Lemmens Valery E. P. P., Siersema Peter D., Hulshof Maarten C. C. M., Verhoeven Rob H. A., Nieuwenhuijzen Grard A. P. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer Annals of surgery 2018;267 (2):303-310 [PubMed]
  • Noordman B. J., Verdam M. G. E., Lagarde S. M., Shapiro J., Hulshof M. C. C. M., van Berge Henegouwen M. I., Wijnhoven B. P. L., Nieuwenhuijzen G. A. P., Bonenkamp J. J., Cuesta M. A., Plukker J. Th M., Spillenaar Bilgen E. J., Steyerberg E. W., van der Gaast A., Sprangers M. A. G., van Lanschot J. J. B. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial Annals of oncology 2018;29 (2):445-451 [PubMed]
  • Noordman Bo Jan, van Klaveren David, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., Gisbertz Suzanne S., Lagarde Sjoerd M., van der Gaast Ate, Hulshof Maarten C. C. M., Biermann Katharina, Steyerberg Ewout W., van Lanschot J. Jan B. Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy Annals of surgery 2018;267 (5):892-897 [PubMed]
  • Lagarde Sjoerd M., Anderegg Martinus C. J., Gisbertz Suzanne S., Meijer Sybren L., Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., van Laarhoven Hanneke W. M., Henegouwen Mark I. van Berge Lymph node metastases near the celiac trunk should be considered separately from other nodal metastases in patients with cancer of the esophagus or gastroesophageal junction after neoadjuvant treatment and surgery Journal of thoracic disease 2018;10 (3):1511-1521 [PubMed]
  • Mari Luigi, Hoefnagel Sanne J. M., Zito Domenico, van de Meent Marian, van Endert Peter, Calpe Silvia, Sancho Serra Maria del Carmen, Heemskerk Mirjam H. M., van Laarhoven Hanneke W. M., Hulshof Maarten C. C. M., Gisbertz Susanne S., Medema Jan Paul, van Berge Henegouwen Mark I., Meijer Sybren L., Bergman Jacques J. G. H. M., Milano Francesca, Krishnadath Kausilia K. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients Gastroenterology 2018;155 (3):784-798 [PubMed]
  • Coebergh van den Braak R. R. J., van Rijssen L. B., van Kleef J. J., Vink G. R., Berbee M., van Berge Henegouwen M. I., Bloemendal H. J., Bruno M. J., Burgmans M. C., Busch O. R. C., Coene P. P. L. O., Coupé V. M. H., Dekker J. W. T., van Eijck C. H. J., Elferink M. A. G., Erdkamp F. L. G., van Grevenstein W. M. U., de Groot J. W. B., van Grieken N. C. T., de Hingh I. H. J. T., Hulshof M. C. C. M., Ijzermans J. N. M., Kwakkenbos L., Lemmens V. E. P. P., Los M., Meijer G. A., Molenaar I. Q., Nieuwenhuijzen G. A. P., de Noo M. E., van de Poll-Franse L. V., Punt C. J. A., Rietbroek R. C., Roeloffzen W. W. H., Rozema T., Ruurda J. P., van Sandick J. W., Schiphorst A. H. W., Schipper H., Siersema P. D., Slingerland M., Sommeijer D. W., Spaander M. C. W., Sprangers M. A. G., Stockmann H. B. A. C., Strijker M., van Tienhoven G., Timmermans L. M., Tjin-A-Ton M. L. R., van der Velden A. M. T., Verhaar M. J., Verkooijen H. M., Vles W. J., de Vos-Geelen J. M. P. G. M., Wilmink J. W., Zimmerman D. D. E., van Oijen M. G. H., Koopman M., Besselink M. G. H., van Laarhoven H. W. M. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative Acta oncologica (Stockholm, Sweden) 2018;57 (2):195-202 [PubMed]
  • Borggreve A. S., Mook S., Verheij M., Mul V. E. M., Bergman J. J., Bartels-Rutten A., ter Beek L. C., Beets-Tan R. G. H., Bennink R. J., van Berge Henegouwen M. I., Brosens L. A. A., Defize I. L., van Dieren J. M., Dijkstra H., van Hillegersberg R., Hulshof M. C., van Laarhoven H. W. M., Lam M. G. E. H., van Lier A. L. H. M. W., Muijs C. T., Nagengast W. B., Nederveen A. J., Noordzij W., Plukker J. T. M., van Rossum P. S. N., Ruurda J. P., van Sandick J. W., Weusten B. L. A. M., Voncken F. E. M., Yakar D., Meijer G. J., Aleman B. M. P., Borra R. J. H., van Etten B., Gisbertz S. S., Goense L., Haj Mohammad N., Hartemink K. J., Kappert P., Kats-Ugurlu G., Kodach L. L., Korteweg T., Krishnadath K. K., Langendijk J. A., de Leng W. W. J., Meijer S. L., Potze J. H., Stoker J., Vegt E., Verkooijen H. M., Vollenbrock S. E., Wessels F. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study BMC cancer 2018;18 (1) [PubMed]
  • Larue Ruben T. H. M., Klaassen Remy, Jochems Arthur, Leijenaar Ralph T. H., Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., Schreurs Wendy M. J., Sosef Meindert N., van Elmpt Wouter, van Laarhoven Hanneke W. M., Lambin Philippe Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer Acta oncologica (Stockholm, Sweden) 2018;57 (11):1475-1481 [PubMed]
  • Groot Harmke J., Gietema Jourik A., Aleman Berthe M. P., Incrocci Luca, de Wit Ronald, Witjes J. Alfred, Groenewegen Gerard, de Brouwer Peter, Meijer Otto W. M., Hulshof Maarten C. C. M., van den Berg Hetty A., Smilde Tineke J., Vanneste Ben G. L., Aarts Maureen J., van den Bergh Alphonsus C. M., Kerst J. Martijn, van den Belt-Dusebout Alexandra W., Lubberts Sjoukje, Jóźwiak Katarzina, Horenblas Simon, van Leeuwen Flora E., Schaapveld Michael Risk of diabetes after para-aortic radiation for testicular cancer British journal of cancer 2018;119 (7):901-907 [PubMed]
  • Jin Peng, van Wieringen Niek, Hulshof Maarten C. C. M., Bel Arjan, Alderliesten Tanja Tailoring four-dimensional cone-beam CT acquisition settings for fiducial marker-based image guidance in radiation therapy Journal of medical imaging (Bellingham, Wash.) 2018;5 (2):021207 [PubMed]
  • Creemers Aafke, Ebbing Eva A., Hooijer Gerrit K. J., Stap Lisanne, Jibodh-Mulder Rajni A., Gisbertz Susanne S., Henegouwen Mark I. van Berge, van Montfoort Maurits L., Hulshof Maarten C. C. M., Krishnadath Kausilia K., van Oijen Martijn G. H., Bijlsma Maarten F., Meijer Sybren L., van Laarhoven Hanneke W. M. The dynamics of HER2 status in esophageal adenocarcinoma Oncotarget 2018;9 (42):26787-26799 [PubMed]
  • Schooneveldt G., Kok H. P., Bakker A., Geijsen E. D., Hulshof M. C. C. M., Reijke T. M. de, Crezee J. The effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patients International journal of hyperthermia 2018;35 (1):441-449 [PubMed]
  • van den Ende T., ter Veer E., Machiels M., Mali R. M. A., Abe Nijenhuis F. A., Waal L. D., Laarman M., Gisbertz S. S., Hulshof M. C. C. M., van Oijen M. G. H., van Laarhoven H. W. M. The efficacy and safety of (neo)adjuvant therapy for gastric cancer: A network meta-analysis Annals of oncology 2018;29:viii227 [PubMed]
  • Jeene Paul M., van Laarhoven Hanneke W. M., Hulshof Maarten C. C. M. The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer Best practice & research. Clinical gastroenterology 2018;36-37:53-59 [PubMed]
  • van Putten M., Verhoeven R. H. A., Koëter M., van Laarhoven H. W. M., van Sandick J. W., Plukker J. T. M., Siersema P. D., Hulshof M. C. C. M., Wijnhoven B. P. L., Lemmens V. E. P. P., Nieuwenhuijzen G. A. P. Ziekenhuis van diagnose beïnvloedt kans op curatieve behandeling voor slokdarm- en maagkanker Nederlands tijdschrift voor geneeskunde 2018;162:D1970 [PubMed]
  • van Putten Margreet, Verhoeven Rob H. A., Koëter Marijn, van Laarhoven Hanneke W. M., van Sandick Johanna W., Plukker John T. M., Siersema Peter D., Hulshof Maarten C. C. M., Wijnhoven Bas P. L., Lemmens Valery E. P. P., Nieuwenhuijzen Grard A. P. Ziekenhuis van diagnose beïnvloedt kans op curatieve behandeling voor slokdarm- en maagkanker: Een pleidooi voor regionaal tumorspecifiek multidisciplinair overleg Nederlands tijdschrift voor geneeskunde 2018;62 (12)

2017

  • van Stam Gerard, Kok H. Petra, Hulshof Maarten C. C. M., Kolff M. Willemijn, van Tienhoven Geertjan, Sijbrands Jan, Bakker Akke, Zum Vörde Sive Vörding Paul J., Oldenborg Sabine, de Greef Martijn, Rasch Coen R. N., Crezee Hans A flexible 70 MHz phase-controlled double waveguide system for hyperthermia treatment of superficial tumours with deep infiltration International journal of hyperthermia 2017;33 (7):796-809 [PubMed]
  • Hulshof Martinus C. C. M., Leliveld-Kors Anna M., Bins Adriaan D. Blaassparende behandeling bij het spierinvasief blaascarcinoom Nederlands tijdschrift voor oncologie 2017;14 (4):132-137
  • Jeene P. M., Versteijne E., van Berge Henegouwen M. I., Bergmann J. J. G. H. M., Geijsen E. D., Muller K., van Laarhoven H. W. M., Hulshof M. C. C. M. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment Diseases of the esophagus 2017;30 (2):1-5 [PubMed]
  • Crezee Johannes, van Tienhoven Geertjan, Kolff Merel W., Sijbrands Jan, van Stam Gerard, Oldenborg Sabine, Geijsen Elisabeth D., Hulshof Maarten C. C. M., Kok Henny P. Development of a 70 MHz unit for hyperthermia treatment of deep-seated breast tumorsin: 2016 46th European Microwave Conference (EuMC). IEEE; 2017. p. 906-909
  • Crezee Johannes, van Tienhoven Geertjan, Kolff Merel W., Sijbrands Jan, van Stam Gerard, Oldenborg Sabine, Geijsen Elisabeth D., Hulshof Maarten C. C. M., Kok Henny P. Development of a 70 MHz unit for hyperthermia treatment of deep-seated breast tumors INTERNATIONAL JOURNAL OF MICROWAVE AND WIRELESS TECHNOLOGIES 2017;9 (6):1317-1324
  • Koëter M., Kathiravetpillai N., Gooszen J. A., van Berge Henegouwen M. I., Gisbertz S. S., van der Sangen M. J. C., Luyer M. D. P., Nieuwenhuijzen G. A. P., Hulshof M. C. C. M. Influence of the Extent and Dose of Radiation on Complications After Neoadjuvant Chemoradiation and Subsequent Esophagectomy With Gastric Tube Reconstruction With a Cervical Anastomosis International journal of radiation oncology, biology, physics 2017;97 (4):813-821 [PubMed]
  • Jin Peng, Hulshof Maarten C. C. M., van Wieringen Niek, Bel Arjan, Alderliesten Tanja Interfractional variability of respiration-induced esophageal tumor motion quantified using fiducial markers and four-dimensional cone-beam computed tomography Radiotherapy and oncology 2017;124 (1):147-154 [PubMed]
  • Markar S. R., Noordman B. J., Mackenzie H., Findlay J. M., Boshier P. R., Ni M., Steyerberg E. W., van der Gaast A., Hulshof M. C. C. M., Maynard N., van Berge Henegouwen M. I., Wijnhoven B. P. L., Reynolds J. V., van Lanschot J. J. B., Hanna G. B. Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study Annals of oncology 2017;28 (3):519-527 [PubMed]
  • van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M. Neoadjuvant chemotherapy in oesophageal adenocarcinoma lancet oncology 2017;18 (11):e639
  • van Laarhoven Hanneke W. M., Pijnenburg Lisa J., Hulshof Maarten C. C. M. On the Receiving End of Autonomy and Law oncologist 2017;22 (9):1143-1145 [PubMed]
  • Anderegg M. C. J., van der Sluis P. C., Ruurda J. P., Gisbertz S. S., Hulshof M. C. C. M., van Vulpen M., Mohammed N. Haj, van Laarhoven H. W. M., Wiezer M. J., Los M., van Berge Henegouwen M. I., van Hillegersberg R. Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma Annals of surgical oncology 2017;24 (8):2282-2290 [PubMed]
  • Jeene Paul M., Versteijne Eva, van Berge Henegouwen Mark I., Bergmann Jacques J. G. H. M., Geijsen Elisabeth D., van Laarhoven Hanneke W. M., Hulshof Maarten C. C. M. Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation Acta oncologica (Stockholm, Sweden) 2017;56 (1):33-38 [PubMed]
  • Butter R., Lagarde S. M., van Oijen M. G. H., Anderegg M. C. J., Gisbertz S. S., Meijer S. L., Hulshof M. C. C. M., Bergman J. J. G. H. M., van Berge Henegouwen M. I., van Laarhoven H. W. M. Treatment strategies in recurrent esophageal or junctional cancer Diseases of the esophagus 2017;30 (9):1-9 [PubMed]
  • van Moorselaar R. J. A., Hulshof M. C. C. M., van Leenders G. J. L. H., Gerritsen W. R., van Poppel H. Tumoren van de urinewegenin: C. J. H. Van de Velde, W. T. A. Van der Graaf, J. H. J. M. Van Krieken, C. A. M. Marijnen, editors. Leerboek oncologie. Houten: Bohn Stafleu Van Loghum; 2017. p. 473-491, ISBN 9789036804417
  • Jelvehgaran Pouya, Alderliesten Tanja, Weda Jelmer J. A., de Bruin Martijn, Faber Dirk J., Hulshof Maarten C. C. M., van Leeuwen Ton G., van Herk Marcel, de Boer Johannes F. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study Medical physics 2017;44 (12):6570-6582 [PubMed]

2016

  • Lutkenhaus L. J., Vestergaard A., Bel A., Høyer M., Hulshof M. C. C. M., van Leeuwen C. M., Casares-Magaz O., Petersen J. B., Søndergaard J., Muren L. P. A biological modeling based comparison of two strategies for adaptive radiotherapy of urinary bladder cancer Acta oncologica (Stockholm, Sweden) 2016;55 (8):1009-1015 [PubMed]
  • Haj Mohammad Nadia, de Rooij Sophia, Hulshof Maarten, Ruurda Jelle, Wijnhoven Bas, Erdkamp Frans, Sosef Meindert, Gisbertz Suzanne, van Berge Henegouwen Mark, Sprangers Mirjam, van Laarhoven Hanneke Activities of daily living and quality of life during treatment with neoadjuvant chemoradiotherapy and after surgery in patients with esophageal cancer Journal of surgical oncology 2016;114 (6):684-690 [PubMed]
  • Hulshof M. C. C. M., van Laarhoven H. W. M. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction Best practice & research. Clinical gastroenterology 2016;30 (4):551-563 [PubMed]
  • Lutkenhaus Lotte J., van Os Rob M., Bel Arjan, Hulshof Maarten C. C. M. Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients Radiation oncology (London, England) 2016;11 (1):45 [PubMed]
  • van der Woude Stephanie O., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study Chinese clinical oncology 2016;5 (1):UNSP 13 [PubMed]
  • Haj Mohammad Nadia Daily clinical practice and patterns of care in upper gastrointestinal cancer treatment 2016. 271p. ISBN 9789462334649. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Laarhoven H. W. M., Lemmens V. E. P. P.; Co-supervisors: van Oijen M. G. H., Hulshof M. C. C. M.)
  • Machiels Melanie, Wouterse Sanne J., Geijsen Elisabeth D., van Os Rob M., Bennink Roel J., van Laarhoven Hanneke Wm, Hulshof Maarten Ccm Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy Journal of medical imaging and radiation oncology 2016;60 (4):520-527 [PubMed]
  • Schooneveldt G., Kok H. P., Balidemaj E., Geijsen E. D., van Ommen F., Sijbrands J., Bakker A., de la Rosette J. J. M. C. H., Hulshof M. C. C. M., de Reijke T. M., Crezee J. Improving hyperthermia treatment planning for the pelvis by accurate fluid modeling Medical physics 2016;43 (10):5442 [PubMed]
  • Lutkenhaus Lotte Potential benefit and clinical implementation of adaptive radiotherapy 2016. 169p. ISBN 9789402803099. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Rasch C. R. N.; Co-supervisors: Bel A., Hulshof M. C. C. M.)
  • Shapiro J., van Klaveren D., Lagarde S. M., Toxopeus E. L. A., van der Gaast A., Hulshof M. C. C. M., Wijnhoven B. P. L., van Berge Henegouwen M. I., Steyerberg E. W., van Lanschot J. J. B. Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgery British journal of surgery 2016;103 (8):1039-1047 [PubMed]
  • Anderegg Maarten C. J., Lagarde Sjoerd M., Jagadesham Vamshi P., Gisbertz Suzanne S., Immanuel Arul, Meijer Sybren L., Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., van Laarhoven Hanneke W. M., Griffin S. Michael, van Berge Henegouwen Mark I. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction Annals of surgery 2016;264 (5):847-853 [PubMed]
  • Jin Peng, Hulshof Maarten C. C. M., de Jong Rianne, van Hooft Jeanin E., Bel Arjan, Alderliesten Tanja Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography Radiotherapy and oncology 2016;118 (3):492-497 [PubMed]
  • Schooneveldt Gerben, Bakker Akke, Balidemaj Edmond, Chopra Rajiv, Crezee Johannes, Geijsen Elisabeth D., Hartmann Josefin, Hulshof Maarten C. C. M., Kok H. Petra, Paulides Margarethus M., Sousa-Escandon Alejandro, Stauffer Paul R., Maccarini Paolo F. Thermal dosimetry for bladder hyperthermia treatment. An overview International journal of hyperthermia 2016;32 (4):417-433 [PubMed]

2015

  • Anderegg Maarten C. J., de Groof Elisabeth J., Gisbertz Suzanne S., Bennink Roel J., Lagarde Sjoerd M., Klinkenbijl Jean H. G., Dijkgraaf Marcel G. W., Bergman Jacques J. G. H. M., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I. 18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making PLoS ONE 2015;10 (11):e0133690 [PubMed]
  • Noordman Bo Jan, Shapiro Joel, Spaander Manon C. W., Krishnadath Kausilia K., van Laarhoven Hanneke W. M., van Berge Henegouwen Mark I., Nieuwenhuijzen Grard A. P., van Hillegersberg Richard, Sosef Meindert N., Steyerberg Ewout W., Wijnhoven Bas P. L., van Lanschot J. Jan B., Shapiro Joël, Biermann Katharina, van der Gaast Ate, Krak Nanda C., van Rij Caroline, Valkema Roelf, Bennink Roel J., Hulshof Maarten C. C. M., Meijer Sybren L., Haj Mohammad Nadia, Hobbelink Monique G. G., van Leeuwen Maarten S., Offerhaus G. Johan A., Reerink Onne, Siersema Peter D., Creemers Geert-Jan, Roef Mark J., van der Sangen Maurice J. C., Schoon Erik J., Buijsen Jeroen, Nap Marius, Oostenbrug Liekele, Schreurs Wendu M. J., Warmerdam Fabienne A. R. M. Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol JMIR research protocols 2015;4 (2):e79 [PubMed]
  • Haj Mohammad N., Walter A. W., van Oijen M. G. H., Hulshof M. C. C. M., Bergman J. J. G. H. M., Anderegg M. C. J., van Berge Henegouwen M. I., Henselmans I., Sprangers M. A. G., van Laarhoven H. W. M. Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent Supportive care in cancer 2015;23 (12):3589-3598 [PubMed]
  • Stalpers Lukas J. A., Hulshof Maarten C. C. M. Cutaneous Melanomain: Renate G. Pannizon, M. Heinrich Seegenschmiedt, editors. Radiation Treatment and Radiation Reactions in Dermatology. New York: Springer; 2015. p. 165-171, ISBN 9783662448250; 9783662448267
  • Versteijne E., van Laarhoven H. W. M., van Hooft J. E., van Os R. M., Geijsen E. D., van Berge Henegouwen M. I., Hulshof M. C. C. M. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern Diseases of the esophagus 2015;28 (5):453-459 [PubMed]
  • Shapiro Joel, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van der Gaast Ate Effectiveness of Neoadjuvant Chemoradiotherapy for Early-Stage Esophageal Cancer Journal of clinical oncology 2015;33 (3):288-289 [PubMed]
  • Machiels Melanie, van Hooft Jeanin, Jin Peng, van Berge Henegouwen Mark I., van Laarhoven Hanneke M., Alderliesten Tanja, Hulshof Maarten C. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers Gastrointestinal endoscopy 2015;82 (4):641-649 [PubMed]
  • Lutkenhaus Lotte J., Visser Jorrit, de Jong Rianne, Hulshof Maarten C. C. M., Bel Arjan Evaluation of delivered dose for a clinical daily adaptive plan selection strategy for bladder cancer radiotherapy Radiotherapy and oncology 2015;116 (1):51-56 [PubMed]
  • Klaassen Remy, Bennink Roelof J., van Tienhoven Geertjan, Bijlsma Maarten F., Besselink Marc G. H., van Berge Henegouwen Mark I., Wilmink Johanna W., Nederveen Aart J., Windhorst Albert D., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M. Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer Radiotherapy and oncology 2015;116 (1):94-99 [PubMed]
  • Jin Peng, van der Horst Astrid, de Jong Rianne, van Hooft Jeanin E., Kamphuis Martijn, van Wieringen Niek, Machiels Melanie, Bel Arjan, Hulshof Maarten C. C. M., Alderliesten Tanja Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer Radiotherapy and oncology 2015;117 (3):412-418 [PubMed]
  • Spierings L. E. A. M. M., Lagarde S. M., van Oijen M. G. H., Gisbertz S. S., Wilmink J. W., Hulshof M. C. C. M., Meijer S. L., Anderegg M. C., van Berge Henegouwen M. I., van Laarhoven H. W. M. Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes Annals of surgical oncology 2015;22 (Suppl. 3):S766-S771 [PubMed]
  • Shapiro Joel, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Hagen Pieter, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., ten Kate Fiebo J. W., Creemers Geert-Jan M., Punt Cornelis J. A., Plukker John Th M., Verheul Henk M. W., Bilgen Ernst J. Spillenaar, van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., Steyerberg Ewout W., van der Gaast Ate Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial lancet oncology 2015;16 (9):1090-1098 [PubMed]
  • Haj Mohammad Nadia, Kamphuis Martijn, Hulshof Maarten C. C. M., Lutkenhaus Lotte J., Gisbertz Suzanne S., Bergman Jacques J. G. H. M., de Bruin-Bon Rianne H. A. C. M., Geijsen Elisabeth D., Bel Arjan, Boekholdt S. Mathijs, van Laarhoven Hanneke W. M. Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer Radiotherapy and oncology 2015;114 (1):91-95 [PubMed]
  • Lutkenhaus Lotte J., Kamphuis Martijn, van Wieringen Niek, Hulshof Maarten C. C. M., Bel Arjan Regarding Edmunds et al. Cardiac volume effects during chemoradiotherapy for esophageal cancer Radiotherapy and oncology 2015;114 (1):130 [PubMed]

2014

  • Haj Mohammad Nadia, Hulshof Maarten C. C. M., Bergman Jacques J. G. H. M., Geijsen Debby, Wilmink Johanna W., van Berge Henegouwen Mark I., van Laarhoven Hanneke W. M. Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma BMC cancer 2014;14 (1):56 [PubMed]
  • Blom R. L. G. M., Sosef M. N., Nap M., Lammering G., van den Berkmortel F., Hulshof M. C. C. M., Meijer S. L., Wilmink H. W., van Berge Henegouwen M. I. Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma Diseases of the esophagus 2014;27 (4):380-387 [PubMed]
  • Alderliesten T., Hulshof Maarten C., Bel A. De ontwikkeling en mogelijkheden van beeldgeleide radiotherapie Nederlands tijdschrift voor oncologie 2014;11 (1):13-19
  • Goossens-Laan Catharina A., Leliveld Anna M., Verhoeven Rob H. A., Kil Paul J. M., de Bock Geertruida H., Hulshof Maarten C. C. M., de Jong Igle J., Coebergh Jan Willem W. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer International journal of cancer. Journal international du cancer 2014;135 (4):905-912 [PubMed]
  • Koen Talsma A., Shapiro Joel, Looman Caspar W. N., van Hagen Pieter, Steyerberg Ewout W., van der Gaast Ate, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., ten Kate Fiebo J. W., Creemers Geert-Jan, Punt Cornelis J. A., Plukker John T. M., Verheul Henk M. W., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., van Rij Caroline Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival Annals of surgery 2014;260 (5):786-92; discussion 792-3 [PubMed]
  • Oppedijk Vera, van der Gaast Ate, van Lanschot Jan J. B., van Hagen Pieter, van Os Rob, van Rij Caroline M., van der Sangen Maurice J., Beukema Jannet C., Rütten Heidi, Spruit Patty H., Reinders Janny G., Richel Dick J., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials Journal of clinical oncology 2014;32 (5):385-391 [PubMed]
  • Kordes Sil, van Berge Henegouwen Mark I., Hulshof Maarten C., Bergman Jacques J. G. H. M., van der Vliet Hans J., Kapiteijn Ellen, van Laarhoven Hanneke W. M., Richel Dick J., Klinkenbijl Jean H. G., Meijer Sybren L., Wilmink Johanna W. Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study International journal of radiation oncology, biology, physics 2014;90 (1):190-196 [PubMed]
  • Trip Anouk K., Poppema Boelo J., van Berge Henegouwen Mark I., Siemerink Ester, Beukema Jannet C., Verheij Marcel, Plukker John T. M., Richel Dick J., Hulshof Maarten C. C. M., van Sandick Johanna W., Cats Annemieke, Jansen Edwin P. M., Hospers Geke A. P. Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study Radiotherapy and oncology 2014;112 (2):284-288 [PubMed]
  • Shapiro Joel, van Hagen Pieter, Lingsma Hester F., Wijnhoven Bas P. L., Biermann Katharina, ten Kate Fiebo J. W., Steyerberg Ewout W., van der Gaast Ate, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Berge Henegouwen Mark I., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., Creemers Geert-Jan, Punt Cornelis J. A., Plukker John T. M., Verheul Henk M. W., Spillenaar Bilgen Ernst J., van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W. Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer Annals of surgery 2014;260 (5):807-814 [PubMed]
  • Hulshof Maarten C. C. M., Oppedijk Vera, van der Gaast Ate Reply to E. C. Smyth et al Journal of clinical oncology 2014;32 (27):3081-3082 [PubMed]
  • Gwynne S., Wijnhoven B. P. L., Hulshof M., Bateman A. Role of chemoradiotherapy in oesophageal cancer -- adjuvant and neoadjuvant therapy Clinical oncology (Royal College of Radiologists (Great Britain)) 2014;26 (9):522-532 [PubMed]

2013

  • Hulshof Maarten C. C. M., Pieters Bradley R., Koning Caro C. E. Blaassparende behandelingen bij blaaskanker: mogelijkheden en ontwikkelingen in de radiotherapie Nederlands tijdschrift voor geneeskunde 2013;157 (19):A5556 [PubMed]
  • Wognum S., Bondar L., Zolnay A. G., Chai X., Hulshof M. C. C. M., Hoogeman M. S., Bel A. Control over structure-specific flexibility improves anatomical accuracy for point-based deformable registration in bladder cancer radiotherapy Medical physics 2013;40 (2):021702 [PubMed]
  • Dees-Ribbers Hermine M., Pos Floris J., Betgen Anja, Bex Axel, Hulshof Maarten C. C. M., Remeijer Peter, van Herk Marcel Fusion of planning CT and cystoscopy images for bladder tumor delineation: a feasibility study Medical physics 2013;40 (5):051713 [PubMed]
  • Blom R. L. G. M., van Heijl M., Klinkenbijl J. H. G., Bergman J. J. G. H. M., Wilmink J. W., Richel D. J., Hulshof M. C. C. M., Reitsma J. B., Busch O. R. C., van Berge Henegouwen M. I. Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70 Diseases of the esophagus 2013;26 (5):510-516 [PubMed]
  • Cordeiro Ernesto R., Geijsen Debby E., Zum Vörde Sive Vörding Paul J., Schooneveldt Gerben, Sijbrands Jan, Hulshof Maarten C., de la Rosette Jean, de Reijke Theo M., Crezee Hans Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study Journal of endourology / Endourological Society 2013;27 (12):1504-1509 [PubMed]
  • van Hagen P., Hulshof M. C. C. M., van Lanschot J. J. B., Steyerberg E. W., van Berge Henegouwen M. I., Wijnhoven B. P. L., Richel D. J., Reinders J. G., Tilanus H. W., van der Gaast A. Preoperatieve chemoradiotherapie voor carcinoom van slokdarm of slokdarm-maagovergang* Nederlands tijdschrift voor geneeskunde 2013;157 (6):A5682 [PubMed]
  • Lutkenhaus Lotte J., Kamphuis Martijn, van Wieringen Niek, Hulshof Maarten C. C. M., Bel Arjan Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer Radiotherapy and oncology 2013;109 (2):200-203 [PubMed]
  • Blom Rachel L., Lagarde Sjoerd M., van Oudenaarde Kim, Klinkenbijl Jean H. G., Hulshof Maarten C., van Laarhoven Hanneke W., Bergman Jacques J., Busch Olivier R., van Berge Henegouwen Mark I. Survival after recurrent esophageal carcinoma has not improved over the past 18 years Annals of surgical oncology 2013;20 (8):2693-2698 [PubMed]
  • Sauer R., Crezee H., Hulshof M., Issels R., Ott O., van Rhoon G. The letter of the Ludwig Boltzmann Institute is unnecessarily polarizing to the discussion on whether or not hypothermia is evidence based Reply Strahlentherapie und Onkologie 2013;189 (1):84-86

2012

  • Chai Xiangfei, van Herk Marcel, Betgen Anja, Hulshof Maarten, Bel Arjan Automatic bladder segmentation on CBCT for multiple plan ART of bladder cancer using a patient-specific bladder model Physics in medicine and biology 2012;57 (12):3945-3962 [PubMed]
  • Chai Xiangfei, van Herk Marcel, Hulshof Maarten C. C. M., Bel Arjan A voxel-based finite element model for the prediction of bladder deformation Medical physics 2012;39 (1):55-65 [PubMed]
  • Han Peter, Rotman Marvin, Schulsinger Alan R., Pieters Bradley R., Koning Caro C. E., Pos Floris J., Hulshof Maarten C. C. M., Poortmans Philip Bladder Cancerin: Seymour H. Levitt, James A. Purdy, Carlos A. Perez, Philip Poortmans, editors. Technical Basis of Radiation Therapy. Berlin: Springer; 2012. p. 801-827, ISBN 9783642115721; 9783642115714
  • Hirdes Meike M. C., van Hooft Jeanin E., Wijrdeman Harm K., Hulshof Maarten C. C. M., Fockens Paul, Reerink Onne, van Oijen Martijn G. H., van der Tweel Ingeborg, Vleggaar Frank P., Siersema Peter D. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer Gastrointestinal endoscopy 2012;76 (2):267-274 [PubMed]
  • Sauer R., Creeze H., Hulshof M., Issels R., Ott O. Concerning the final report "Hyperthermia: a systematic review" of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010 Strahlentherapie und Onkologie 2012;188 (3):209-213 [PubMed]
  • van Rooijen Dominique Improving radiation dose delivery for moving targets using image guidance 2012. 134p. ISBN 9789088914126. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Koning C. C. E.; Co-supervisors: Bel A., Hulshof M. C. C. M.)
  • van Hagen P., Hulshof M. C. C. M., van Lanschot J. J. B., Steyerberg E. W., van Berge Henegouwen M. I., Wijnhoven B. P. L., Richel D. J., Nieuwenhuijzen G. A. P., Hospers G. A. P., Bonenkamp J. J., Cuesta M. A., Blaisse R. J. B., Busch O. R. C., ten Kate F. J. W., Creemers G.-J., Punt C. J. A., Plukker J. T. M., Verheul H. M. W., Spillenaar Bilgen E. J., van Dekken H., van der Sangen M. J. C., Rozema T., Biermann K., Beukema J. C., Piet A. H. M., van Rij C. M., Reinders J. G., Tilanus H. W., van der Gaast A., Bergman J. J. G. H. M., Bartelsman J. F., Bissumbar A., Blom R. L., Geijsen E. D., van Heijl M., Obertop H., Koning C. C. E., Offerhaus G. J., Omloo J. M., Wilmink H., Aparicio Pages M. N., van den Nieuwenhof-Biesheuvel L., Eijkenboom W. M. H., Koppert L. B., Meijer D. A., Siersema P. D., Spaander M. C. V., Verheij C., Vollebregt C., van Krieken J. H. J. M. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer New England journal of medicine 2012;366 (22):2074-2084 [PubMed]
  • Chai Xiangfei, van Herk Marcel, Betgen Anja, Hulshof Maarten, Bel Arjan Semiautomatic bladder segmentation on CBCT using a population-based model for multiple-plan ART of bladder cancer Physics in medicine and biology 2012;57 (24):N525-N541 [PubMed]
  • Goossens-Laan Catharina A., Visser Otto, Hulshof Maarten C. C. M., Wouters Michel W., Bosch J. L. H. Ruud, Coebergh Jan-Willem W., Kil Paul J. M. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume BJU international 2012;110 (2):226-232 [PubMed]

2011

  • van Heijl M., Phoa S. S. K. S., van Berge Henegouwen M. I., Omloo J. M. T., Mearadji B. M., Sloof G. W., Bossuyt P. M. M., Hulshof M. C. C. M., Richel D. J., Bergman J. J. G. H. M., ten Kate F. J. W., Stoker J., van Lanschot J. J. B. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer European journal of surgical oncology 2011;37 (12):1064-1071 [PubMed]
  • Chai Xiangfei, van Herk Marcel, van de Kamer Jeroen B., Hulshof Maarten C. C. M., Remeijer Peter, Lotz Heidi T., Bel Arjan Finite element based bladder modeling for image-guided radiotherapy of bladder cancer Medical physics 2011;38 (1):142-150 [PubMed]
  • van Heijl Mark, Omloo Jikke M., van Berge Henegouwen Mark I., Hoekstra Otto S., Boellaard Ronald, Bossuyt Patrick M., Busch Olivier R., Tilanus Hugo W., Hulshof Maarten C., van der Gaast Ate, Nieuwenhuijzen Grard A., Bonenkamp Han J., Plukker John Th, Cuesta Miguel A., ten Kate Fiebo J., Pruim Jan, van Dekken Herman, Bergman Jacques J., Sloof Gerrit W., van Lanschot J. Jan Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer Annals of surgery 2011;253 (1):56-63 [PubMed]

2010

  • Chai Xiangfei, van Herk Marcel, van de Kamer Jeroen B., Remeijer Peter, Bex Axel, Betgen Anja, de Reijke Theo M., Hulshof Maarten C. C. M., Pos Floris J., Bel Arjan BEHAVIOR OF LIPIODOL MARKERS DURING IMAGE GUIDED RADIOTHERAPY OF BLADDER CANCER International journal of radiation oncology, biology, physics 2010;77 (1):309-314 [PubMed]
  • Petra Kok H., de Greef Martijn, van Wieringen Niek, Correia Davi, Hulshof Maarten C. C. M., Zum Vörde Sive Vörding Paul J., Sijbrands Jan, Bel Arjan, Crezee Johannes Comparison of two different 70 MHz applicators for large extremity lesions: Simulation and application International journal of hyperthermia 2010;26 (4):376-388 [PubMed]
  • van Rooijen D. C., van de Kamer J. B., Hulshof M. C. C. M., Koning C. C. E., Bel A. Improving bladder cancer treatment with radiotherapy using separate intensity modulated radiotherapy plans for boost and elective fields Journal of medical imaging and radiation oncology 2010;54 (3):256-263 [PubMed]
  • van Rooijen Dominique C., Pool René, van de Kamer Jeroen B., Hulshof Maarten C. C. M., Koning Caro C. E., Bel Arjan Independent position correction on tumor and lymph nodes; consequences for bladder cancer irradiation with two combined IMRT plans Radiation oncology (London, England) 2010;5:53 [PubMed]
  • Hulshof M. C. C. M., van Haaren P. M. A., Zum Vörde Sive Vörding P. J., Krishnadath S., Marsman W. A., van Berge Henegouwen M. I., Geijsen E. D., Crezee J. Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus Diseases of the esophagus 2010;23 (8):E42-E47 [PubMed]
  • Goossens-Laan C. A., Visser O., Wouters M. W. J. M., Jansen-Landheer M. L. E. A., Coebergh J. W. W., van de Velde C. J. H., Hulshof M. C. C. M., Kil P. J. M. Variations in treatment policies and outcome for bladder cancer in the Netherlands European journal of surgical oncology 2010;36 (Suppl. 1):S100-S107 [PubMed]

2009

  • Overgaard J., Gonzalez Gonzalez D., Hulshof M. C. C. H., Arcangeli G., Dahl O., Mella O., Bentzen S. M. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996 International journal of hyperthermia 2009;25 (5):323-334 [PubMed]
  • Crezee J., van Haaren P. M. A., Westendorp H., de Greef M., Kok H. P., Wiersma J., van Stam G., Sijbrands J., Zum Vörde Sive Vörding P., van Dijk J. D. P., Hulshof M. C. C. M., Bel A. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: A preclinical study International journal of hyperthermia 2009;25 (7):581-592 [PubMed]
  • Hulshof M. C. C. M., van Haaren P. M. A., van Lanschot J. J. B., Richel D. J., Fockens P., Oldenborg S., Geijsen E. D., van Berge Henegouwen M. I., Crezee J. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer International journal of hyperthermia 2009;25 (1):79-85 [PubMed]
  • Crezee Johannes, Barendsen Gerrit W., Westermann Anneke M., Hulshof Maarten C. C. M., Haveman Jaap, Stalpers Lukas J. A., Geijsen E. Debby, Franken Nicolaas A. P. QUANTIFICATION OF THE CONTRIBUTION OF HYPERTHERMIA TO RESULTS OF CERVICAL CANCER TRIALS: IN REGARD TO PLATANIOTIS AND DALE (INT J RADIAT ONCOL BIOL PHYS 2009;73:1538-1544) International journal of radiation oncology, biology, physics 2009;75 (2):634 [PubMed]
  • van Rooijen Dominique C., van de Kamer Jeroen B., Pool Rene, Hulshof Maarten C. C. M., Koning Caro C. E., Bel Arjan The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer Radiation oncology (London, England) 2009;4 (1):38 [PubMed]

2008

  • Piet Anna H. M., Hulshof Maarten C. C. M., Pieters Bradley R., Pos Floris J., de Reijke Theo M., Koning Caro C. E. Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer Strahlentherapie und Onkologie 2008;184 (6):313-318 [PubMed]
  • Westerterp Marinke, Boermeester Marja A., Omloo Jikke M. T., Hulshof Maarten C. C. M., Vervenne Walter L., Lutter Rene, Out Theo A., van Lanschot J. Jan B. Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus Cancer immunology, immunotherapy 2008;57 (12):1837-1847 [PubMed]
  • van Heijl Mark, Omloo Jikke M. T., van Berge Henegouwen Mark I., Busch Olivier R. C., Tilanus Hugo W., Bossuyt Patrick M. M., Hoekstra Otto S., Stoker Jaap, Hulshof Maarten C. C. M., van der Gaast Ate, Nieuwenhuijzen Grard A. P., Bonenkamp Han J., Plukker John Th M., Spillenaar Bilgen Ernst J., ten Kate Fibo J. W., Boellaard Ronald, Pruim Jan, Sloof Gerrit W., van Lanschot J. Jan B. NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial) BMC medical physics 2008;8 (1):3 [PubMed]
  • van Haaren P. M. A., Hulshof M. C. C. M., Kok H. P., Oldenborg S., Geijsen E. D., van Lanschot J. J. B., Crezee J. Relation between body size and temperatures during locoregional hyperthermia of oesophageal cancer patients International journal of hyperthermia 2008;24 (8):663-674 [PubMed]
  • Koot R. W., Habraken J. B. A., Hulshof M. C. C. M., Paans A. M. J., Bosch D. A., Pruim J. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by Ir-192 brachytherapy? Acta neurochirurgica 2008;150 (4):345-349 [PubMed]

2007

  • Hulshof Maarten C. C. M., van Andel George, Bel Arjen, Gangel Pieter, van de Kamer Jeroen B. Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas Radiotherapy and oncology 2007;84 (1):49-51 [PubMed]

2006

  • Pos Floris J., Hulshof Maarten, Lebesque Joos, Lotz Heidi, van Tienhoven Geertjan, Moonen Luc, Remeijer Peter Adaptive radiotherapy for invasive bladder cancer: a feasibility study International journal of radiation oncology, biology, physics 2006;64 (3):862-868 [PubMed]
  • Pieters Bradley R., van der Grient Johan N. B., Blank Leo E. C. M., Koedooder Kees, Hulshof Maarten C. C. M., de Reijke Theo M. Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants Radiotherapy and oncology 2006;80 (1):69-72 [PubMed]
  • Westerterp M., Omloo J. M. T., Sloof G. W., Hulshof M. C. C. M., Hoekstra O. S., Crezee H., Boellaard R., Vervenne W. L., ten Kate F. J. W., van Lanschot J. J. B. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET Journal of clinical gastroenterology 2006;40 (Suppl. 4):S180-ev
  • Westerterp Marinke, Omloo Jikke M. T., Sloof Gerrit W., Hulshof Maarten C. C. M., Hoekstra Otto S., Crezee Hans, Boellaard Ronald, Vervenne Walter L., ten Kate Fiebo J. W., van Lanschot Jan J. B. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET International journal of hyperthermia 2006;22 (2):149-160 [PubMed]
  • Kok H. P., van Haaren P. M. A., van de Kamer J. B., Zum Vörde Sive Vörding P. J., Wiersma J., Hulshof M. C. C. M., Geijsen E. D., van Lanschot J. J. B., Crezee J. Prospective treatment planning to improve locoregional hyperthermia for oesophageal cancer International journal of hyperthermia 2006;22 (5):375-389 [PubMed]
  • Pos F. J. Radiotherapy in muscle invasive bladder cancer 2006. 179p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Bartelink G. M. M.; Co-supervisor: Hulshof M. C. C. M.)
  • van Haaren P. M. A., Kok H. P., Zum Vörde Sive Vörding P. J., van Dijk J. D. P., Hulshof M. C. C. M., Fockens P., van Lanschot J. J. B., Crezee J. Reliability of temperature and SAR measurements at oesophageal tumour locations International journal of hyperthermia 2006;22 (7):545-561 [PubMed]
  • Lotz Heidi T., Pos Floris J., Hulshof Maarten C. C. M., van Herk Marcel, Lebesque Joos V., Duppen Joop C., Remeijer Peter Tumor motion and deformation during external radiotherapy of bladder cancer International journal of radiation oncology, biology, physics 2006;64 (5):1551-1558 [PubMed]

2005

  • Rades Dirk, Stalpers Lukas J. A., Hulshof Maarten C., Borgmann Kerstin, Karstens Johann H., Koning Caro C. E., Alberti Winfried Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression International journal of radiation oncology, biology, physics 2005;62 (2):514-518 [PubMed]
  • Rades Dirk, Stalpers Lukas J. A., Hulshof Maarten C. C. M., Zschenker Oliver, Alberti Winfried, Koning Caro C. E. Effectiveness and toxicity of single-fraction radiotherapy with 1 X 8 Gy for metastatic spinal cord compression Radiotherapy and oncology 2005;75 (1):70-73 [PubMed]
  • Haveman J., Sminia P., Wondergem J., van der Zee J., Hulshof M. C. C. M. Effects of hyperthermia on the central nervous system: What was learnt from animal studies? International journal of hyperthermia 2005;21 (5):473-487 [PubMed]
  • Rades Dirk, Stalpers Lukas J. A., Veninga Theo, Schulte Rainer, Hoskin Peter J., Obralic Nermina, Bajrovic Amira, Rudat Volker, Schwarz Rudolf, Hulshof Maarten C., Poortmans Philip, Schild Steven E. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression Journal of clinical oncology 2005;23 (15):3366-3375 [PubMed]

2004

  • Albregts M., Hulshof M. C. C. M., Zum Vörde Sive Vörding P. J., van Lanschot J. J. B., Richel D. J., Crezee H., Fockens P., van Dijk J. D. P., González González D. A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery International journal of hyperthermia 2004;20 (6):647-659 [PubMed]
  • Hulshof M. C. C. M., Raaymakers B. W., Lagendijk J. J. W., Koot R. W., Crezee H., Stalpers L. J. A., González González D. A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the Multi Electrode Current Source (MECS) system International journal of hyperthermia 2004;20 (5):451-463 [PubMed]
  • van Andel G., Visser A. P., Zwinderman A. H., Hulshof M. C. C. M., Horenblas S., Kurth K. H. A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients Prostate 2004;58 (4):354-365 [PubMed]
  • Pieters B. R., Hulshof M. C. C. M. D plaats van radiotherapie in de behandeling van het prostaatcarcinoom Nederlands tijdschrift voor oncologie 2004 (5):190-197
  • Haveman J., van der Zee J., Wondergem J., Hoogeveen J. F., Hulshof M. C. C. M. Effects of hyperthermia on the peripheral nervous system: a review International journal of hyperthermia 2004;20 (4):371-391 [PubMed]
  • Koot R. W., de Heer K., Oort F. J., Hulshof M. C. C. M., Bosch D. A., de Haes J. C. J. M. Quality of life after brachytherapy in patients with glioblastoma multiforme European journal of cancer (Oxford, England 2004;40 (7):1013-1020 [PubMed]

2003

  • Pos Floris J., van Tienhoven Geertjan, Hulshof Maarten C. C. M., Koedooder Kees, González González Dionisio Concomitant boost radiotherapy for muscle invasive bladder cancer Radiotherapy and oncology 2003;68 (1):75-80 [PubMed]
  • van Andel G., Visser A. P., Hulshof M. C. C. M., Horenblas S., Kurth K. H. Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy BJU international 2003;92 (3):217-222 [PubMed]
  • Pos Floris J., Koedooder Kees, Hulshof Maarten C. C. M., van Tienhoven Geertjan, González González Dionisio Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy International journal of radiation oncology, biology, physics 2003;55 (3):835-841 [PubMed]
  • van der Zee J., Hulshof M. C. C. M. Lessons learned from hyperthermia International journal of radiation oncology, biology, physics 2003;57 (2):596-7; author reply 599-600 [PubMed]
  • Hulshof M. C. C. M. Nieuwe ontwikkelingen bij bestraling hersentumoren Tijdschrift Kanker 2003;3:38-39

2002

  • Koot Radboud W., Maarouf Mohammad, Hulshof Maarten C. C. M., Voges Jürgen, Treuer Harald, Koedooder Cees, Sturm Volker, Bosch Andries D. Analysis of the recurrence in relation to the plannings target volume (PTV) for brachytherapy or external beam radiation therapy (EBRT) Cancer 2002;94 (8):2316-2317 [PubMed]
  • Hulshof Maarten C. C. M., Stark Nienke M., van der Kleij Ad, Sminia Peter, Smeding Harriet M. M., Gonzalez Gonzalez Dionisio Hyperbaric oxygen therapy for cognitive disorders after irradiation of the brain Strahlentherapie und Onkologie 2002;178 (4):192-198 [PubMed]
  • Hulshof M. C. C. M. Modification of radiation effects in patients with glioblatoma multiforme 2002. 146p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: González González D., Bosch D. A.; Co-supervisor: Stalpers L. J. A.)
  • Sminia Peter, Oldenburger Foppe, Slotman Ben J., Schneider Christoph J., Hulshof Maarten C. C. M. Re-irradiation of the human spinal cord Strahlentherapie und Onkologie 2002;178 (8):453-456 [PubMed]

2001

  • Hartmann K. A., van der Kleij A. J., Carl U. M., Hulshof M. C., Willers R., Sminia P. Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H International journal of radiation oncology, biology, physics 2001;51 (4):1037-1044 [PubMed]
  • Goedegebure A., Hulshof M., Maas R. J., Dreschler W. A., Verschuure H. Effects of single-channel phonemic compression schemes on the understanding of speech by hearing-impaired listeners Audiology 2001;40 (1):10-25 [PubMed]
  • Hulshof M. C., Koot R. W., Schimmel E. C., Dekker F., Bosch D. A., González González D. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution Strahlentherapie und Onkologie 2001;177 (6):283-290 [PubMed]
  • Hulshof M. C., Sminia P., Barten-van Rijbroek A. D., Gonzalez Gonzalez D. Prognostic value of plasma transforming growth factor-beta in patients with glioblastoma multiforme Oncology reports 2001;8 (5):1107-1110 [PubMed]

2000

  • Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme Cancer 2000;88 (12):2796-2802 [PubMed]
  • Hypofractionation in glioblastoma multiforme Radiotherapy and oncology 2000;54 (2):143-148 [PubMed]

1999

  • Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933 Journal of clinical oncology 1999;17 (10):3143-3149 [PubMed]

1998

  • De samenhang tussen de serumconcentratie van prostaatspecifiek antigeen en de skelet- en CT-scan bij de stagering van primair prostaatcarcinoom Nederlands tijdschrift voor geneeskunde 1998;142 (20):1142-1146 [PubMed]
  • Hyperthermia and the central nervous system Progress in brain research 1998;115:337-350 [PubMed]
  • Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study Radiotherapy and oncology 1998;48 (2):135-142 [PubMed]
  • Management of benign lymphoepithelial lesions of the parotid gland in human immunodeficiency virus-positive patients European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) 1998;255 (8):427-429 [PubMed]
  • Treatment planning of brain implants using vascular information and a new template technique IEEE transactions on medical imaging 1998;17 (5):729-736 [PubMed]

1997

  • Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas European journal of cancer (Oxford, England 1997;33 (4):645-651 [PubMed]

1996

  • Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology International journal of hyperthermia 1996;12 (1):3-20 [PubMed]
  • Irradiation induced osteosarcoma in the posterior cranial fossa six years after surgery and radiation for medulloblastoma Journal of neurology, neurosurgery, and psychiatry 1996;61 (4):429-430 [PubMed]

1995

  • Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology Lancet 1995;345 (8949):540-543 [PubMed]

1994

  • Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study Radiotherapy and oncology 1994;32 (2):98-105 [PubMed]

1993

  • Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer (NSCLC) Radiotherapy and oncology 1993;28 (3):247-251 [PubMed]
  • Treatment results in primary intraspinal gliomas Radiotherapy and oncology 1993;29 (3):294-300 [PubMed]